Mirabegron 50mg 1 Prolonged Release Tablet [Prescription Required]
Indication: For the symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as
may occur in adult patients with overactive bladder (OAB) syndrome.
Contraindication: Mirabegron (Betmiga®,) is contraindicated in patients with:
- Hypersensitivity to the active substance or to any of the excipients listed in List of excipients.
- Severe uncontrolled hypertension defined as systolic blood pressure &ge,180 mm Hg and/or diastolic blood pressure &ge,110 mm Hg.
Place of Origin
The recommended dose is 50 mg once daily with or without food.
List of excipients
May increase BP. Patients w/ congenital or acquired QT prolongation